![Lars Ekman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Ekman
Directeur/Membre du Conseil chez
PROTHENA CORPORATION PLC
Fortune : 2 474 $ au 31/05/2026
Profil
Dr. Lars G.
Ekman is a Chairman-Emeritus at Prothena Corp.
Plc, an Executive Partner, Private Equity at Sofinnova Investments, Inc., a Chairman at AFYX Therapeutics AS, a Chairman at Prothena Biosciences, Inc. and a Chief Auditor at Codemill AB. He is on the Board of Directors at Prothena Corp.
Plc.
Dr. Ekman was previously employed as an Independent Director by Ultragenyx Pharmaceutical, Inc., an Independent Director by Spark Therapeutics, Inc., an Executive Chairman by Sophiris Bio, Inc., an Independent Director by OCERA Therapeutics LLC, a Non-Executive Director by Amarin Corp.
Plc, a Chief Executive Officer by Cebix, Inc., a Lead Independent Director by InterMune, Inc., a Non-Executive Director by Elan Corp.
Plc, an EVP, President-Research & Development by Elan Pharmaceuticals, Inc., an Executive Vice President-Research & Development by Schwartz Pharma AG, an Executive Vice President by Pharmacia GmbH, a Principal by Pharmacia Corp., and a Chairman by Poseida Therapeutics, Inc. He also served on the board at Ocera Therapeutics, Inc. /Old/ and ARYx Therapeutics, Inc. He received his doctorate degree from the University of Gothenburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2026 | 243 ( 0 % ) | 2 474 $ | 31/05/2026 |
Postes actifs de Lars Ekman
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Directeur/Membre du Conseil | 14/05/2024 |
| CODEMILL AB | Comptroller/Controller/Auditor | - |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical biotechnology company that develops novel and transformative medicines | Président | 16/10/2013 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/03/2007 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Président | - |
Anciens postes connus de Lars Ekman
| Sociétés | Poste | Fin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 07/06/2023 |
| AMARIN CORPORATION PLC | Président | 19/05/2022 |
| SOPHIRIS BIO | Président | 01/01/2020 |
| SPARK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/12/2019 |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Lars Ekman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Schwartz Pharma AG
 Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Health Technology |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops therapeutics for gastrointestinal and liver diseases | Health Technology |
University of Gothenburg
 University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia GmbH | |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Prothena Biosciences, Inc.
Prothena Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical biotechnology company that develops novel and transformative medicines | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Codemill AB
 Codemill AB Packaged SoftwareTechnology Services Develops media and video applications | Technology Services |
AFYX Therapeutics AS
AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
